Advertisement
GEVO vs GPRE
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GEVO is a Buy and GPRE is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
GEVO’s FA Score shows that 1 FA rating(s) are green whileGPRE’s FA Score has 1 green FA rating(s).
- GEVO’s FA Score: 1 green, 4 red.
- GPRE’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
GEVO’s TA Score shows that 5 TA indicator(s) are bullish while GPRE’s TA Score has 5 bullish TA indicator(s).
- GEVO’s TA Score: 5 bullish, 6 bearish.
- GPRE’s TA Score: 5 bullish, 4 bearish.
Price Growth
GEVO (@Chemicals: Specialty) experienced а 0.00% price change this week, while GPRE (@Chemicals: Major Diversified) price change was +24.41% for the same time period.
The average weekly price growth across all stocks in the @Chemicals: Specialty industry was +0.13%. For the same industry, the average monthly price growth was +9.90%, and the average quarterly price growth was +13.31%.
The average weekly price growth across all stocks in the @Chemicals: Major Diversified industry was +0.40%. For the same industry, the average monthly price growth was +6.42%, and the average quarterly price growth was +1.50%.
Reported Earning Dates
GEVO is expected to report earnings on Nov 05, 2025.
GPRE is expected to report earnings on Oct 30, 2025.
Industries' Descriptions
@Chemicals: Specialty (+0.13% weekly)The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.
@Chemicals: Major Diversified (+0.40% weekly)The major diversified chemicals industry includes companies that produce a wide range of chemicals and industrial gases. The products are often used as raw materials in the manufacturing of various types of goods, including plastics, paints, carpets, and fixtures to name a few. Major companies making diversified chemicals include DuPont de Nemours Inc., Celanese Corporation, Celanese Corporation and Westlake Chemical Corporation.
| GEVO | GPRE | GEVO / GPRE | |
| Capitalization | 418M | 728M | 57% |
| EBITDA | -25.54M | 26.5M | -96% |
| Gain YTD | -17.225 | 17.194 | -100% |
| P/E Ratio | N/A | N/A | - |
| Revenue | 80.2M | 2.4B | 3% |
| Total Cash | 57.3M | 109M | 53% |
| Total Debt | 171M | 568M | 30% |
GEVO | GPRE | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 91 | 84 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 71 Overvalued | 94 Overvalued | |
PROFIT vs RISK RATING 1..100 | 91 | 100 | |
SMR RATING 1..100 | 94 | 95 | |
PRICE GROWTH RATING 1..100 | 37 | 35 | |
P/E GROWTH RATING 1..100 | 33 | 2 | |
SEASONALITY SCORE 1..100 | n/a | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
GEVO's Valuation (71) in the Chemicals Specialty industry is in the same range as GPRE (94). This means that GEVO’s stock grew similarly to GPRE’s over the last 12 months.
GEVO's Profit vs Risk Rating (91) in the Chemicals Specialty industry is in the same range as GPRE (100). This means that GEVO’s stock grew similarly to GPRE’s over the last 12 months.
GEVO's SMR Rating (94) in the Chemicals Specialty industry is in the same range as GPRE (95). This means that GEVO’s stock grew similarly to GPRE’s over the last 12 months.
GPRE's Price Growth Rating (35) in the Chemicals Specialty industry is in the same range as GEVO (37). This means that GPRE’s stock grew similarly to GEVO’s over the last 12 months.
GPRE's P/E Growth Rating (2) in the Chemicals Specialty industry is in the same range as GEVO (33). This means that GPRE’s stock grew similarly to GEVO’s over the last 12 months.
| GEVO | GPRE | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 81% | 3 days ago 82% |
| Stochastic ODDS (%) | 3 days ago 86% | 3 days ago 87% |
| Momentum ODDS (%) | 3 days ago 84% | 3 days ago 81% |
| MACD ODDS (%) | 3 days ago 75% | 3 days ago 83% |
| TrendWeek ODDS (%) | 3 days ago 84% | 3 days ago 76% |
| TrendMonth ODDS (%) | 3 days ago 83% | 3 days ago 74% |
| Advances ODDS (%) | 7 days ago 83% | 3 days ago 74% |
| Declines ODDS (%) | 17 days ago 86% | 14 days ago 82% |
| BollingerBands ODDS (%) | 3 days ago 83% | 3 days ago 83% |
| Aroon ODDS (%) | 3 days ago 87% | 3 days ago 84% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| PHSZX | 42.92 | 0.08 | +0.19% |
| PGIM Jennison Health Sciences Z | |||
| DGEZX | 13.64 | 0.02 | +0.15% |
| Destinations Equity Income Z | |||
| PUMYX | 15.04 | N/A | N/A |
| PACE Small/Medium Co Growth Equity Y | |||
| ASVIX | 10.54 | -0.01 | -0.09% |
| American Century Small Cap Value Inv | |||
| HLMOX | 9.07 | -0.01 | -0.11% |
| Harding Loevner Frontier Emerg Mkts Inv | |||
GEVO and
Correlation & Price change
A.I.dvisor indicates that over the last year, GEVO has been loosely correlated with PX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if GEVO jumps, then PX could also see price increases.
| Ticker / NAME | Correlation To GEVO | 1D Price Change % | ||
|---|---|---|---|---|
| GEVO | 100% | N/A | ||
| PX - GEVO | 38% Loosely correlated | +0.22% | ||
| BASFY - GEVO | 35% Loosely correlated | -0.97% | ||
| MNTK - GEVO | 35% Loosely correlated | -3.59% | ||
| AMTX - GEVO | 35% Loosely correlated | -6.27% | ||
| CLMT - GEVO | 32% Poorly correlated | -0.18% | ||
More | ||||
GPRE and
Correlation & Price change
A.I.dvisor indicates that over the last year, GPRE has been loosely correlated with REX. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if GPRE jumps, then REX could also see price increases.
| Ticker / NAME | Correlation To GPRE | 1D Price Change % | ||
|---|---|---|---|---|
| GPRE | 100% | +0.09% | ||
| REX - GPRE | 53% Loosely correlated | -2.40% | ||
| ALB - GPRE | 42% Loosely correlated | N/A | ||
| MEOH - GPRE | 41% Loosely correlated | -0.59% | ||
| LYB - GPRE | 41% Loosely correlated | +0.88% | ||
| DD - GPRE | 41% Loosely correlated | -0.39% | ||
More | ||||